<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: To investigate a possible implication of inflammatory processes in the development of <z:hpo ids='HP_0000726'>dementia</z:hpo> in cerebrovascular disease </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS AND METHODS: We examined the levels of interleukin-6 (IL-6) in the cerebrospinal fluid (CSF) of patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) (n = 26), ischemic cerebrovascular disease without <z:hpo ids='HP_0000726'>dementia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) (n = 11), vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VD) (n = 11), and other <z:e sem="disease" ids="C1112108" disease_type="Disease or Syndrome" abbrv="">neurological disorders</z:e> (n = 21) using sensitive enzyme-linked immunosorbent assay </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: The CSF concentrations of IL-6 were significantly elevated in patients with VD compared with those of patients with AD or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>CONCLUSION: The CSF IL-6 levels are increased in patients with VD, suggesting that inflammatory mechanisms may be involved in the development of <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> in some patients with cerebrovascular disease </plain></SENT>
<SENT sid="4" pm="."><plain>CSF IL-6 may be a biological marker for <z:hpo ids='HP_0000726'>dementia</z:hpo> in cerebrovascular disease </plain></SENT>
</text></document>